Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.
about
The multifaceted role of natriuretic peptides in metabolic syndrome.Short term variation in NTproBNP after lifestyle intervention in severe obesity.NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato StudyNatriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes.
P2860
Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.
@en
type
label
Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.
@en
prefLabel
Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.
@en
P2860
P1476
Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity
@en
P2093
Cedric Moro
P2860
P304
P356
10.1080/14728222.2016.1254198
P407
P50
P577
2016-11-09T00:00:00Z